PATENTS ARE a powerful tool for asserting intellectual property rights—they offer innovators profitable exclusive rights, thereby providing incentive for critical (and costly) investments in research and development. However, this exclusivity is limited in time. After 20 years (from application), patents expire and generic producers can practice the invention. The enhanced competitiveness of the market typically brings additional Patent Expiration, Product Concentration, and Glyphosate Use: A Tale of Unexpected Consequences by GianCarlo Moschini, Edward Perry, and David Hennessy moschini@iastate.edu; edperry@ksu.edu; hennes64@msu.edu benefits to final users. Not much is expected to go wrong when a critical patent on a major product expires—...
299-306A patent is an exclusive right awarded by the intellectual property (IP) authority of a state...
This paper seeks to explain why some pharmaceutical companies are observed to withdraw their product...
International audienceObjectives: To stimulate drug R&D, regulatory agencies in the United States (U...
PATENTS ARE a powerful tool for asserting intellectual property rights—they offer innovators profita...
International audienceGovernments are trying to stimulate drug R&D for unmet health needs with publi...
This paper investigates patterns of industrial dynamics and competition in the pharmaceutical indust...
My research focuses on pharmaceutical patents and their effect on the availability of medicine. Beca...
This paper attempts to estimate the change in sales associated with pharmaceutical patent expiration...
How does the expiration of a pharmaceutical firms’ drug patent affect the firms’ R&D decisions? We a...
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of ...
The pharmaceutical business is dominated largely by two types of entities: large, research-intensive...
Drug patents are distorted. Unlike most other inventors, drug inventors must complete years of testi...
tion pharmaceuticals—Prilosec, Prozac, Pepcid, and Claritin, for ex-ample—faced patent expiration. W...
Patent protection has proven particularly important to the pharmaceutical sector among R&D-intensive...
<div><p>Background</p><p>Not all new drug products are truly new. Some are the result of marginal in...
299-306A patent is an exclusive right awarded by the intellectual property (IP) authority of a state...
This paper seeks to explain why some pharmaceutical companies are observed to withdraw their product...
International audienceObjectives: To stimulate drug R&D, regulatory agencies in the United States (U...
PATENTS ARE a powerful tool for asserting intellectual property rights—they offer innovators profita...
International audienceGovernments are trying to stimulate drug R&D for unmet health needs with publi...
This paper investigates patterns of industrial dynamics and competition in the pharmaceutical indust...
My research focuses on pharmaceutical patents and their effect on the availability of medicine. Beca...
This paper attempts to estimate the change in sales associated with pharmaceutical patent expiration...
How does the expiration of a pharmaceutical firms’ drug patent affect the firms’ R&D decisions? We a...
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of ...
The pharmaceutical business is dominated largely by two types of entities: large, research-intensive...
Drug patents are distorted. Unlike most other inventors, drug inventors must complete years of testi...
tion pharmaceuticals—Prilosec, Prozac, Pepcid, and Claritin, for ex-ample—faced patent expiration. W...
Patent protection has proven particularly important to the pharmaceutical sector among R&D-intensive...
<div><p>Background</p><p>Not all new drug products are truly new. Some are the result of marginal in...
299-306A patent is an exclusive right awarded by the intellectual property (IP) authority of a state...
This paper seeks to explain why some pharmaceutical companies are observed to withdraw their product...
International audienceObjectives: To stimulate drug R&D, regulatory agencies in the United States (U...